MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acsami.5c25024

Медицинская библиотека · ACS applied materials & interfaces · 2026

Validation of DoriVac (DNA Origami Vaccine) Efficacy in a Metastatic Melanoma Model.

Rajwar Anjali, Dembele Hawa, Graveline Amanda R, Vernet Andyna, Sanchez Melinda, Bardales Sarai, Kwon Ick Chan, Ryu Ju Hee, Shih William M, Zeng Yang C

СтатьяПеревод пока не подготовлен

Аннотация

Metastatic cancer, particularly metastatic melanoma, poses a significant therapeutic challenge due to its resistance to standard treatments and a low five-year survival rate of 20-27%. Recent advances in cancer vaccine research show great promise in reducing disease recurrence, but these approaches still face challenges pertaining to antigen selection, ease of production, and programmability. To address some of these challenges, we have adapted the DoriVac platform to serve as a cancer vaccine against metastatic melanoma. DoriVac is a DNA origami-based vaccine platform that allows for the codelivery of antigens of choice and the CpG immune adjuvant at an optimal nanospacing to promote Th1 immune polarization. In our study, we observed a significant reduction in lung tumor nodules in the B16OVA and B16F10 melanoma models for DoriVac-treated mice. DoriVac also appears to be a safe treatment, as we did not observe any significant increase in antinanoparticle (i.e., anti-dsDNA) antibodies. Importantly, we observed an enhanced effect when DoriVac was combined with an αPD-L1 immune checkpoint blockade, leading to an even greater reduction in metastatic lung tumor nodules. Our results also indicate an increased activation of antigen-presenting cells, NK cells, CD4+ T cells, and CD8+ T cells in comparison to the control groups. These findings suggest that DoriVac, particularly in combination with the αPD-L1 immune checkpoint blockade, can serve as a promising immunotherapy against metastatic cancer.

Для цитирования: Rajwar Anjali, Dembele Hawa, Graveline Amanda R, Vernet Andyna, Sanchez Melinda, Bardales Sarai, Kwon Ick Chan, Ryu Ju Hee, Shih William M, Zeng Yang C. Validation of DoriVac (DNA Origami Vaccine) Efficacy in a Metastatic Melanoma Model.. ACS applied materials & interfaces. 2026. DOI: 10.1021/acsami.5c25024.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.